Prostaglandin E2 release evoked by intrathecal dynorphin is dependent on spinal p38 mitogen activated protein kinase

Camilla I. Svensson, Xiao Ying Hua, Henry C. Powell, Josephine Lai, Frank Porreca, Tony L. Yaksh

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Spinal dynorphin has been hypothesized to play a pivotal role in spinal sensitization. Although the mechanism of this action is not clear, several lines of evidence suggest that spinal dynorphin-induced hyperalgesia is mediated through an increase in spinal cyclooxygenase products via an enhanced N-methyl-d-aspartate (NMDA) receptor function. Spinal NMDA-evoked prostaglandin release and nociception has been linked to the activation of p38 mitogen activated protein kinase (p38). In the present work, we show that intrathecal delivery of an N-truncated fragment of dynorphin A, dynorphin A 2-17 (dyn 2-17), which has no activity at opioid receptors, induced a 8-10-fold increase in phosphorylation of p38 in the spinal cord. The increase in phosphorylated p38 was detected in laminae I-IV of the dorsal horn. Moreover, confocal microscopy showed that the activation of p38 occurred in microglia, but not in neurons or astrocytes. In awake rats, prepared with chronically placed intrathecal loop dialysis catheters, the concentration of prostaglandin E 2 in lumbar cerebrospinal fluid was increased 5-fold by intrathecal administration of dyn2-17. Injection of SD-282, a selective p38 inhibitor, but not PD98059, an ERK1/2 inhibitor, attenuated the prostaglanin E2 release. These data, taken together, support the hypothesis that dynorphin, independent of effects mediated by opioid receptors, has properties that can induce spinal sensitization and indicates that dyn2-17 effects may be mediated through activation of the p38 pathway. These studies provide an important downstream linkage where by dynorphin may act through a non-neuronal link to induce a facilitation of spinal nociceptive processing.

Original languageEnglish (US)
Pages (from-to)485-494
Number of pages10
JournalNeuropeptides
Volume39
Issue number5
DOIs
StatePublished - Oct 2005

Fingerprint

Dynorphins
p38 Mitogen-Activated Protein Kinases
Dinoprostone
Chemical activation
Opioid Receptors
Cerebrospinal fluid
Phosphorylation
Nociception
Dialysis
Confocal microscopy
Catheters
Hyperalgesia
Microglia
Prostaglandin-Endoperoxide Synthases
Prostaglandins E
Aspartic Acid
Confocal Microscopy
Astrocytes
Neurons
Prostaglandins

Keywords

  • Dialysis
  • Dyn
  • Dynorphin
  • ERK
  • Intrathecal
  • Microglia
  • p38
  • Pain
  • Prostaglandin E
  • Spinal cord

ASJC Scopus subject areas

  • Endocrinology
  • Clinical Neurology
  • Endocrinology, Diabetes and Metabolism
  • Cellular and Molecular Neuroscience
  • Neuroscience(all)
  • Biochemistry

Cite this

Prostaglandin E2 release evoked by intrathecal dynorphin is dependent on spinal p38 mitogen activated protein kinase. / Svensson, Camilla I.; Hua, Xiao Ying; Powell, Henry C.; Lai, Josephine; Porreca, Frank; Yaksh, Tony L.

In: Neuropeptides, Vol. 39, No. 5, 10.2005, p. 485-494.

Research output: Contribution to journalArticle

Svensson, Camilla I. ; Hua, Xiao Ying ; Powell, Henry C. ; Lai, Josephine ; Porreca, Frank ; Yaksh, Tony L. / Prostaglandin E2 release evoked by intrathecal dynorphin is dependent on spinal p38 mitogen activated protein kinase. In: Neuropeptides. 2005 ; Vol. 39, No. 5. pp. 485-494.
@article{f5e7aaf17b4048488e9ffbf9f2fb8991,
title = "Prostaglandin E2 release evoked by intrathecal dynorphin is dependent on spinal p38 mitogen activated protein kinase",
abstract = "Spinal dynorphin has been hypothesized to play a pivotal role in spinal sensitization. Although the mechanism of this action is not clear, several lines of evidence suggest that spinal dynorphin-induced hyperalgesia is mediated through an increase in spinal cyclooxygenase products via an enhanced N-methyl-d-aspartate (NMDA) receptor function. Spinal NMDA-evoked prostaglandin release and nociception has been linked to the activation of p38 mitogen activated protein kinase (p38). In the present work, we show that intrathecal delivery of an N-truncated fragment of dynorphin A, dynorphin A 2-17 (dyn 2-17), which has no activity at opioid receptors, induced a 8-10-fold increase in phosphorylation of p38 in the spinal cord. The increase in phosphorylated p38 was detected in laminae I-IV of the dorsal horn. Moreover, confocal microscopy showed that the activation of p38 occurred in microglia, but not in neurons or astrocytes. In awake rats, prepared with chronically placed intrathecal loop dialysis catheters, the concentration of prostaglandin E 2 in lumbar cerebrospinal fluid was increased 5-fold by intrathecal administration of dyn2-17. Injection of SD-282, a selective p38 inhibitor, but not PD98059, an ERK1/2 inhibitor, attenuated the prostaglanin E2 release. These data, taken together, support the hypothesis that dynorphin, independent of effects mediated by opioid receptors, has properties that can induce spinal sensitization and indicates that dyn2-17 effects may be mediated through activation of the p38 pathway. These studies provide an important downstream linkage where by dynorphin may act through a non-neuronal link to induce a facilitation of spinal nociceptive processing.",
keywords = "Dialysis, Dyn, Dynorphin, ERK, Intrathecal, Microglia, p38, Pain, Prostaglandin E, Spinal cord",
author = "Svensson, {Camilla I.} and Hua, {Xiao Ying} and Powell, {Henry C.} and Josephine Lai and Frank Porreca and Yaksh, {Tony L.}",
year = "2005",
month = "10",
doi = "10.1016/j.npep.2005.08.002",
language = "English (US)",
volume = "39",
pages = "485--494",
journal = "Neuropeptides",
issn = "0143-4179",
publisher = "Churchill Livingstone",
number = "5",

}

TY - JOUR

T1 - Prostaglandin E2 release evoked by intrathecal dynorphin is dependent on spinal p38 mitogen activated protein kinase

AU - Svensson, Camilla I.

AU - Hua, Xiao Ying

AU - Powell, Henry C.

AU - Lai, Josephine

AU - Porreca, Frank

AU - Yaksh, Tony L.

PY - 2005/10

Y1 - 2005/10

N2 - Spinal dynorphin has been hypothesized to play a pivotal role in spinal sensitization. Although the mechanism of this action is not clear, several lines of evidence suggest that spinal dynorphin-induced hyperalgesia is mediated through an increase in spinal cyclooxygenase products via an enhanced N-methyl-d-aspartate (NMDA) receptor function. Spinal NMDA-evoked prostaglandin release and nociception has been linked to the activation of p38 mitogen activated protein kinase (p38). In the present work, we show that intrathecal delivery of an N-truncated fragment of dynorphin A, dynorphin A 2-17 (dyn 2-17), which has no activity at opioid receptors, induced a 8-10-fold increase in phosphorylation of p38 in the spinal cord. The increase in phosphorylated p38 was detected in laminae I-IV of the dorsal horn. Moreover, confocal microscopy showed that the activation of p38 occurred in microglia, but not in neurons or astrocytes. In awake rats, prepared with chronically placed intrathecal loop dialysis catheters, the concentration of prostaglandin E 2 in lumbar cerebrospinal fluid was increased 5-fold by intrathecal administration of dyn2-17. Injection of SD-282, a selective p38 inhibitor, but not PD98059, an ERK1/2 inhibitor, attenuated the prostaglanin E2 release. These data, taken together, support the hypothesis that dynorphin, independent of effects mediated by opioid receptors, has properties that can induce spinal sensitization and indicates that dyn2-17 effects may be mediated through activation of the p38 pathway. These studies provide an important downstream linkage where by dynorphin may act through a non-neuronal link to induce a facilitation of spinal nociceptive processing.

AB - Spinal dynorphin has been hypothesized to play a pivotal role in spinal sensitization. Although the mechanism of this action is not clear, several lines of evidence suggest that spinal dynorphin-induced hyperalgesia is mediated through an increase in spinal cyclooxygenase products via an enhanced N-methyl-d-aspartate (NMDA) receptor function. Spinal NMDA-evoked prostaglandin release and nociception has been linked to the activation of p38 mitogen activated protein kinase (p38). In the present work, we show that intrathecal delivery of an N-truncated fragment of dynorphin A, dynorphin A 2-17 (dyn 2-17), which has no activity at opioid receptors, induced a 8-10-fold increase in phosphorylation of p38 in the spinal cord. The increase in phosphorylated p38 was detected in laminae I-IV of the dorsal horn. Moreover, confocal microscopy showed that the activation of p38 occurred in microglia, but not in neurons or astrocytes. In awake rats, prepared with chronically placed intrathecal loop dialysis catheters, the concentration of prostaglandin E 2 in lumbar cerebrospinal fluid was increased 5-fold by intrathecal administration of dyn2-17. Injection of SD-282, a selective p38 inhibitor, but not PD98059, an ERK1/2 inhibitor, attenuated the prostaglanin E2 release. These data, taken together, support the hypothesis that dynorphin, independent of effects mediated by opioid receptors, has properties that can induce spinal sensitization and indicates that dyn2-17 effects may be mediated through activation of the p38 pathway. These studies provide an important downstream linkage where by dynorphin may act through a non-neuronal link to induce a facilitation of spinal nociceptive processing.

KW - Dialysis

KW - Dyn

KW - Dynorphin

KW - ERK

KW - Intrathecal

KW - Microglia

KW - p38

KW - Pain

KW - Prostaglandin E

KW - Spinal cord

UR - http://www.scopus.com/inward/record.url?scp=26644469059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26644469059&partnerID=8YFLogxK

U2 - 10.1016/j.npep.2005.08.002

DO - 10.1016/j.npep.2005.08.002

M3 - Article

C2 - 16176831

AN - SCOPUS:26644469059

VL - 39

SP - 485

EP - 494

JO - Neuropeptides

JF - Neuropeptides

SN - 0143-4179

IS - 5

ER -